- •
Surgical site infections (SSIs) are major contributors to patient morbidity and mortality in hospital settings.
- •
Risk for SSI is multifactorial and includes modifiable and nonmodifiable factors.
- •
Basic and clinical research has expanded evidence-based guidelines for SSI prevention.
- •
SSIs are increasingly used as outcome and surrogate measures for examining the quality of surgical care.
- •
A culture of safety and quality is an important element to reducing SSI.
Surgical Site Infections
Section snippets
Key points
Definitions
To assist with appropriate surveillance of SSIs, establishing clear definitions for cases of SSIs was critical. The Centers for Disease Control and Prevention (CDC) established the National Healthcare Safety Network (NHSN) to monitor quality control measures, including SSIs, and has defined widely used definitions for SSI (Box 1).4 SSI are classified based on the depth of involvement of the infection, which may be confined to the skin and subcutaneous tissues (superficial incisional SSI),
Epidemiology
Recognizing the historical context of surgical infection can highlight the gains that have been made over the past few centuries. Before the antisepsis era, the risk of surgery was exceedingly high due to the enormous rates of surgical infection. Compounded by the absence of the effective anesthesia, early surgical procedures had limited success compared with the modern era. Acknowledgment of the aseptic approach made a significant impact on outcomes. The simple introduction of hand washing by
Risk factors for surgical site infection
From a general perspective, the microbes responsible for infection of surgical wounds originate from either the surrounding skin or associated structures that are contiguous with the regions of the surgical procedure. The logical extension of this principle is that the risk of wound contamination and subsequent SSI depends on location, the nature of the surgical wound/incision, and the procedure performed. The CDC wound classification system defines wound class based on risk and is divided into
Microbial factors
The predominant source of microbes involved in SSIs originate from either the skin or the surrounding tissues of the incision, or from deeper structures involved in the operative procedure (eg, enteric organisms in bowel-related surgeries). In the most recent NHSN surveillance report on 21,100 isolates from 2009 to 2010, the most frequently identified pathogens were, in order, Staphylococcus aureus, Coagulase-negative Staphylococci, Escherichia coli, Enterococcus faecalis, and Pseudomonas
Patient factors
Patient comorbidities can contribute significantly to the potential risk of SSIs. These factors include age, obesity, smoking, diabetes mellitus, malnutrition, dyslipidemia, and immunosuppression (see Box 2).41 These factors are not directly accounted for in the NNIS classification scheme but can contribute significantly to the risk of SSI. Identification of these risk factors with appropriate preoperative history and physical examination is critical. The core principle for management of these
Perioperative factors
Preventative measures in the preoperative period have changed rapidly over the past few decades. A large volume of research has established the importance of a host of preventative measures in the operative period. Examples include skin decontamination, perioperative warming, and antimicrobial prophylaxis.41, 44, 45 As additional studies have been conducted with increasing methodological rigor, from observational studies to randomized controlled trials, refinements of existing preventative
Major limitations in prevention
In an ideal scenario, primary prevention is completely effective and the burden of SSI-related morbidity is reduced to 0%. As described in later discussion, the relationship between compliance with evidence-based guidelines and SSI outcomes is imperfect. With the risk inherent with nonmodifiable risk factors, there will likely be a minimum prevalence that cannot be entirely eliminated. In addition, with the development of numerous evidence-based guidelines, there continue to be hurdles with
Therapy
The general principle of SSI therapy remains control of the source of infection. For superficial SSI, the standard management remains the use of incision and drainage.62, 95 The wound should be sufficiently sized to promote adequate drainage. A variety of local wound care options are available, with the simplest being saline-soaked cotton gauze dressings.62 For uncomplicated superficial SSIs, simple incision and drainage, with local wound care, are appropriate, with no antibiotic therapy
The economic and quality of care impact of surgical site infections
The economic costs of SSIs are significant because of the volumes of cases that are seen, with an annual 2.7 million operative procedures performed in the United States.5 Even with a conservative estimate of more than 290,000 cases of SSI,7 there is a substantial economic cost to the management of SSI. There is a wide variance in estimates of the attributable costs of SSI infection that depends heavily on the type of surgical procedure and the geographic region studied.98 There is additional
Summary
SSIs remain a very important component of patient outcome, contributing to substantial patient morbidity. From a historical perspective, there has been a significant improvement in postsurgical outcomes, but these incremental gains have slowed in the recent decades. The translation of basic and clinical research has expanded the complexity of evidence-based guidelines for SSI prevention. The importance of SSI prevention has been heightened because of its association with institutional and
References (107)
Pioneers in infection control—Joseph Lister
J Hosp Infect
(2003)- et al.
CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections
Am J Infect Control
(1992) - et al.
Guideline for prevention of surgical site infection, 1999
Am J Infect Control
(1999) - et al.
The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds
Surg Clin North Am
(1980) - et al.
Nationwide surveillance of antimicrobial susceptibility patterns of pathogens isolated from surgical site infections (SSI) in Japan
J Infect Chemother
(2012) - et al.
Risk of methicillin-resistant Staphylococcus aureus surgical site infection in patients with nasal MRSA colonization
Am J Infect Control
(2013) - et al.
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
Lancet Infect Dis
(2010) - et al.
Global spread of New Delhi metallo-β-lactamase 1
Lancet Infect Dis
(2010) - et al.
Multivariable predictors of postoperative surgical site infection after general and vascular surgery: results from the patient safety in surgery study
J Am Coll Surg
(2007) - et al.
Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures
Ann Thorac Surg
(1999)
Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial
Lancet
Comparative effectiveness of skin antiseptic agents in reducing surgical site infections: a report from the Washington State Surgical Care and Outcomes Assessment Program
J Am Coll Surg
Surgical site infections
Surg Clin North Am
Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project
Am J Surg
Prophylaxis of sternal wound infections with gentamicin-collagen implant: randomized controlled study in cardiac surgery
J Hosp Infect
Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial
Ann Thorac Surg
Gentamicin-collagen sponge reduces sternal wound complications after heart surgery: a controlled, prospectively randomized, double-blind study
J Thorac Cardiovasc Surg
Gentamicin collagen sponges for the prevention of sternal wound infection: a meta-analysis of randomized controlled trials
J Thorac Cardiovasc Surg
Medical advances during the Civil War
Arch Surg
Treatment of war wounds: a historical review
Clin Orthop
The history of surgical infections
Surg Infect (Larchmt)
Estimating health care-associated infections and deaths in U.S. hospitals, 2002
Public Health Rep
Infection in surgical patients: effects on mortality, hospitalization, and postdischarge care
Am J Health Syst Pharm
Surgical site infections, International Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries, 2005-2010
Infect Control Hosp Epidemiol
Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System
Am J Med
Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010
Infect Control Hosp Epidemiol
NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007
Infect Control Hosp Epidemiol
National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986–April 1996, issued May 1996: A report from the National Nosocomial Infections Surveillance (NNIS) System
Am J Infect Control
Is the burden of Staphylococcus aureus among patients with surgical-site infections growing?
Infect Control Hosp Epidemiol
Severe surgical site infection in community hospitals: epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureus
Infect Control Hosp Epidemiol
Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004
J Infect Dis
Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period
J Clin Microbiol
Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05
J Antimicrob Chemother
Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006
Antimicrob Agents Chemother
Lack of upward creep of glycopeptide MICs for methicillin-resistant Staphylococcus aureus (MRSA) isolated in the UK and Ireland 2001-07
J Antimicrob Chemother
Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006
Antimicrob Agents Chemother
Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates
Antimicrob Agents Chemother
Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection
Clin Infect Dis
Is it time to replace vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections?
Clin Infect Dis
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India
Antimicrob Agents Chemother
Carbapenem-resistant Enterobacteriaceae containing New Delhi metallo-beta-lactamase in two patients - Rhode Island, March 2012
MMWR Morb Mortal Wkly Rep
New Delhi metallo-beta-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada
Emerg Infect Dis
Emergence of metallo-beta-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia
Antimicrob Agents Chemother
NDM-1-producing strains, family Enterobacteriaceae, in hospital, Beijing, China
Emerg Infect Dis
Emergence of Klebsiella pneumoniae producing NDM-1 carbapenemase in Saint Petersburg, Russia
J Antimicrob Chemother
Global spread of Carbapenemase-producing Enterobacteriaceae
Emerg Infect Dis
The human microbiome and surgical disease
Ann Surg
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
Proc Natl Acad Sci U S A
Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon
Gut
Intestinal tissues induce an SNP mutation in Pseudomonas aeruginosa that enhances its virulence: possible role in anastomotic leak
PLoS One
Cited by (0)
Disclosures: No conflicts of interest to disclose.